In addition, the somatic mutation of SLC7A11 was barely visible in RCC samples (n = 2/667, 0.3%), which suggested that the aberrant expression of SLC7A11 may result from transcriptional or posttranslational regulation (Figure 2N). Here, SLC7A11 is linked to renal cell carcinoma.